502 related articles for article (PubMed ID: 24071366)
1. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
3. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
Feron O
Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
[TBL] [Abstract][Full Text] [Related]
5. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects.
El Sayed SM; El-Magd RM; Shishido Y; Chung SP; Diem TH; Sakai T; Watanabe H; Kagami S; Fukui K
J Bioenerg Biomembr; 2012 Feb; 44(1):61-79. PubMed ID: 22318356
[TBL] [Abstract][Full Text] [Related]
6. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.
Mathupala SP; Ko YH; Pedersen PL
Semin Cancer Biol; 2009 Feb; 19(1):17-24. PubMed ID: 19101634
[TBL] [Abstract][Full Text] [Related]
7. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
El Sayed SM; Mohamed WG; Seddik MA; Ahmed AS; Mahmoud AG; Amer WH; Helmy Nabo MM; Hamed AR; Ahmed NS; Abd-Allah AA
Chin J Cancer; 2014 Jul; 33(7):356-64. PubMed ID: 24636230
[TBL] [Abstract][Full Text] [Related]
8. 3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor André Goffeau.
Ko YH; Niedźwiecka K; Casal M; Pedersen PL; Ułaszewski S
Yeast; 2019 Apr; 36(4):211-221. PubMed ID: 30462852
[TBL] [Abstract][Full Text] [Related]
9. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
Fukushi A; Kim HD; Chang YC; Kim CH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
[TBL] [Abstract][Full Text] [Related]
10. The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.
Lis P; Dyląg M; Niedźwiecka K; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983708
[TBL] [Abstract][Full Text] [Related]
11. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
[TBL] [Abstract][Full Text] [Related]
12. Introduction to the molecular basis of cancer metabolism and the Warburg effect.
Ngo DC; Ververis K; Tortorella SM; Karagiannis TC
Mol Biol Rep; 2015 Apr; 42(4):819-23. PubMed ID: 25672512
[TBL] [Abstract][Full Text] [Related]
13. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.
Pedersen PL
J Bioenerg Biomembr; 2007 Jun; 39(3):211-22. PubMed ID: 17879147
[TBL] [Abstract][Full Text] [Related]
14. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
16. Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate.
Nijsten MW; van Dam GM
Med Hypotheses; 2009 Jul; 73(1):48-51. PubMed ID: 19264418
[TBL] [Abstract][Full Text] [Related]
17. 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue.
Pedersen PL
J Bioenerg Biomembr; 2012 Feb; 44(1):1-6. PubMed ID: 22382780
[TBL] [Abstract][Full Text] [Related]
18. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting.
Ganapathy-Kanniappan S; Kunjithapatham R; Geschwind JF
Anticancer Res; 2013 Jan; 33(1):13-20. PubMed ID: 23267123
[TBL] [Abstract][Full Text] [Related]
19. ROS and energy metabolism in cancer cells: alliance for fast growth.
Kang SW; Lee S; Lee EK
Arch Pharm Res; 2015 Mar; 38(3):338-45. PubMed ID: 25599615
[TBL] [Abstract][Full Text] [Related]
20. D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.
El Sayed SM; El-Magd RM; Shishido Y; Yorita K; Chung SP; Tran DH; Sakai T; Watanabe H; Kagami S; Fukui K
J Bioenerg Biomembr; 2012 Oct; 44(5):513-23. PubMed ID: 22802136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]